BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory


Mimetas logo


Mimetas is a Dutch company based in Leiden, which specializes in developing organ-on-a-chip models for drug development. Founded in 2013, they raised $32.4M from multiple investors.

The company provides OrganoServices for compound profiling or screening in the human-relative models. Combined with their OrganoPlates, the screening can be performed for multiple compounds using just one plate.

Posts Mentioning This Company

MIMETAS' Recent Milestones in Advancing Drug Discovery Through Organ-on-a-Chip Technology

As the pharmaceutical industry seeks innovative solutions for preclinical development, organ-on-a-chip technology has gained significant traction in recent years. This groundbreaking approach, which emerged in the early 2000s, involves the creation of miniaturized, three-dimensional cell cultures that replicate human organ function within microfluidic devices. These devices, composed of intricate networks …